Biden's bid for re-election, AHIP takes on Pharma and the digital health's equity problems
Biden announces re-election bid
The announcement was expected. A second Biden administration would mean continued implementation of the healthcare provisions of the Inflation Reduction Act, including CMS drug price negotiation and enhanced ACA subsidies. Any talk of Medicare for all is likley to fade into the background. There's no question that Biden campaign believes it can score points by talking about abortion rights. The fourth image in the three-minute campaign video released this morning featured a women holding a sign saying “abortion is healthcare” and at about the 45-second mark, Biden’s voiceover narration mentions what he called MAGA extremists “dictating what healthcare decisions women can make.”
Heavyweight fight: AHIP vs. Pharma
The health insurers' trade association announced yesterday that it was launching a major advertising campaign. “The ads call out how Big Pharma spends millions pointing fingers at others in the health care system to distract Americans from manufacturers’ soaring drug prices – attempting to deflect blame, limit competition, and undermine patients’ bargaining power,” said the news release.
Digital health and the dangers of leaving some behind
In a Health Affairs Forefront blog post this morning, NYU Grossman School of Medicine faculty and researchers discuss the experience of implementing a digital health program for improved blood pressure management at the Park Ridge Family Health Center, a large federally qualified health center in Brooklyn. “As health systems increasingly rely upon technology-facilitated care beyond the pandemic, patients with limited access to technology and low levels of digital literacy face disenfranchisement from their providers,” they warn. But they also have many suggestions for addressing the problem: regular screening for digital literacy, train community health workers for digital outreach, create tipsheets written at 6th grade level and streamline onboarding to eliminate the need for multiple apps.
...and from the inbox
From Stat: Elevance (the health insurer formerly known as Anthem) plowed $3.6 million into lobbying during the first quarter of 2023. And Morphic Therapeutics is reporting positive results for its ulcerative colitis drug.
From Axios Vitals: The morning healthcare newsletter leads with news about efforts to combat Lyme vaccine, which includes two mRNA vaccines in Moderna’s pipeline and the possibility of Lyme disease preexposure prophylaxis (PrEP).
From KFF Health News: The health news organization (formerly known as Kaiser Health News) posted a piece this morning about possible connections between air pollution and mental health. The reporter points to Lilian Calderón-Garcidueñas’s study of brains of 203 Mexico City residents and evidence of neurodegeneration and possible link to exposure to air pollution: “Sussing out the impact of air pollution on the brain has been more difficult than for other organs because of its inaccessibility, so it has not been researched as thoroughly, according to researchers. Whether air pollution may cause or contribute to Alzheimer’s or Parkinson’s is not settled science. But Calderón-Garcidueñas’ work is at the leading edge of showing that air pollution goes directly into the brain through the air we breathe, and has serious impacts.”
Study Highlights Critical Need For Improved Understanding of Childhood Interstitial Lung Disease
December 10th 2024Diagnostic criteria for pulmonary fibrosis and other fibrotic diseases in children are lacking. That void hampers an understanding of how disease progresses in children and adolescents and what the outcomes are.
Read More
Breaking Down Health Plans, HSAs, AI With Paul Fronstin of EBRI
November 19th 2024Featured in this latest episode of Tuning In to the C-Suite podcast is Paul Fronstin, director of health benefits research at EBRI, who shed light on the evolving landscape of health benefits with editors of Managed Healthcare Executive.
Listen
More Than 400 Plastic Chemicals Could Be Linked to Breast Cancer
December 10th 2024Researchers have compiled a list of chemicals commonly found in plastics, including benzophenones, chlorinated paraffins and PFAS, known as “forever chemicals,” and they say there might be a connection to breast cancer.
Read More
In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting Loren McCaghy, director of consulting, health and consumer engagement and product insight at Accenture, to discuss the organization's latest report on U.S. consumers switching healthcare providers and insurance payers.
Listen